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Unedited in vivo detection and quantiﬁcation
of g-aminobutyric acid in the occipital cortex
using short-TE MRS at 3 T
Jamie Neara,b,c*, Jesper Anderssonc, Eduard Marond, Ralf Meklee,f,
Rolf Gruetterf,g, Philip Cowenb and Peter Jezzardc
Short-TE MRS has been proposed recently as a method for the in vivo detection and quantiﬁcation of g-aminobutyric
acid (GABA) in the human brain at 3 T. In this study, we investigated the accuracy and reproducibility of short-TE
MRS measurements of GABA at 3 T using both simulations and experiments. LCModel analysis was performed on
a large number of simulated spectra with known metabolite input concentrations. Simulated spectra were generated
using a range of spectral linewidths and signal-to-noise ratios to investigate the effect of varying experimental
conditions, and analyses were performed using two different baseline models to investigate the effect of an
inaccurate baseline model on GABA quantiﬁcation. The results of these analyses indicated that, under experimental
conditions corresponding to those typically observed in the occipital cortex, GABA concentration estimates are
reproducible (mean reproducibility error, <20%), even when an incorrect baseline model is used. However, simula-
tions indicate that the accuracy of GABA concentration estimates depends strongly on the experimental conditions
(linewidth and signal-to-noise ratio). In addition to simulations, in vivo GABA measurements were performed using
both spectral editing and short-TE MRS in the occipital cortex of 14 healthy volunteers. Short-TE MRS measurements
of GABA exhibited a signiﬁcant positive correlation with edited GABA measurements (R=0.58, p<0.05), suggesting
that short-TE measurements of GABA correspond well with measurements made using spectral editing techniques.
Finally, within-session reproducibility was assessed in the same 14 subjects using four consecutive short-TE GABA
measurements in the occipital cortex. Across all subjects, the average coefﬁcient of variation of these four GABA
measurements was 8.74.9%. This study demonstrates that, under some experimental conditions, short-TE MRS
can be employed for the reproducible detection of GABA at 3 T, but that the technique should be used with caution,
as the results are dependent on the experimental conditions. Copyright © 2013 John Wiley & Sons, Ltd.
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INTRODUCTION
g-Aminobutyric acid (GABA) is the primary inhibitory neurotrans-
mitter in the mammalian brain and plays an important role in the
regulation of neuronal activity (1). Altered tissue GABA levels
have been observed in various pathologies, including both
epilepsy (2) and major depression (3,4), and individual variations
in tissue GABA levels of healthy individuals have been shown to
correlate with both functional MRI activity (5,6) and behaviour
(7,8). In vivo MRS detection of GABA is challenging because of
its relatively low concentration and the large overlapping
resonances from other metabolites and macromolecules (MMs).
As a result, GABA detection is most commonly performed using
spectral editing techniques, which enable the selective observation
of GABA by separation of the C4-GABA multiplet from the back-
ground of overlapping resonances (9–12). Of the available spectral
editing methods, probably the most commonly used is the
Mescher–Garwood point-resolved spectroscopy (MEGA-PRESS)
* Correspondence to: J. Near, FMRIB Centre, Nufﬁeld Department of Clinical
Neurosciences, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK.
E-mail: jnear@fmrib.ox.ac.uk
a J. Near
Douglas Mental Health University Institute and Department of Psychiatry, Mc-
Gill University, Montreal, QC, Canada
b J. Near, P. Cowen
Department of Psychiatry, University of Oxford, Oxford, UK
c J. Near, J. Andersson, P. Jezzard
FMRIB Centre, Nufﬁeld Department of Clinical Neurosciences, University of
Oxford, Oxford, UK
d E. Maron
Faculty of Medicine, Imperial College, London, UK
e R. Mekle
Laboratory for Functional and Metabolic Imaging (LIFMET), Ecole
Polytechnique Federale de Lausanne, Lausanne, Switzerland
f R. Mekle, R. Gruetter
Department of Radiology, University of Lausanne, Lausanne, Switzerland
g R. Gruetter
Centre d’Imagerie Biomedicale, Ecole Polytechnique Federale de Lausanne,
Lausanne, Switzerland
Abbreviations used: CRLB, Cramer–Rao lower bound; GABA, g-aminobutyric
acid; LW, linewidth; MEGA-PRESS, Mescher–Garwood point-resolved spectros-
copy; MM, macromolecule; NAA, N-acetylaspartate; SNR, signal-to-noise ratio;
SPECIAL, spin-echo full-intensity acquired localised; VAPOR, variable power
radiofrequency pulses with optimised relaxation delays.
Research article
Received: 20 January 2012, Revised: 15 March 2013, Accepted: 18 March 2013, Published online in Wiley Online Library: 22 May 2013
(wileyonlinelibrary.com) DOI: 10.1002/nbm.2960
NMR Biomed. 2013; 26: 1353–1362 Copyright © 2013 John Wiley & Sons, Ltd.
1353
technique (10), which combines MEGA editing (10) with PRESS
localisation (13) to achieve reliable quantitative measurements of
GABA concentrations within a localised region of tissue. Studies
have shown that the MEGA-PRESS technique provides reproduc-
ible GABA measurements, with intra-subject reproducibility values
in the range 7–12% (14,15). However, this acquisition method also
has a number of associated drawbacks. First, when optimised for
the observation of GABA, the MEGA-PRESS technique does not
enable the optimal detection of many other metabolites simulta-
neously. Thus, it provides a very limited amount of useful
metabolic information. Second, because the MEGA editing scheme
makes use of narrow-band frequency-selective pulses, it is very sen-
sitive to B0 ﬁeld drift, and small drifts of only a few hertz can affect
signiﬁcantly the quantiﬁcation accuracy (12,16). Third, the tech-
nique is inefﬁcient; the observed GABA signal in the MEGA-PRESS
experiment typically consists of less than 40% of the available
signal from just one of GABA’s three methylene groups (16). The
remainder is lost in the editing process.
Short-TE MRS provides a possible alternative approach for the
detection of GABA, and may provide several advantages over the
more standard spectral editing techniques. Speciﬁcally, short-TE
MRS enables the detection of a large number of metabolites
(including GABA) simultaneously, thus increasing the available
amount of metabolic information. Furthermore, in contrast with
spectral editing techniques, short-TE MRS is relatively insensitive
to B0 ﬁeld drift and is highly efﬁcient as it minimises signal decay
from T2 relaxation and scalar coupling phase evolution. The de-
tection and quantiﬁcation of GABA using short-TE MRS in combi-
nation with LCModel analysis has been demonstrated previously,
but has been mainly restricted to rodent studies and/or very
high ﬁeld strengths (≥7 T) (17–20). Recently, however, Mekle
et al. (21) demonstrated short-TE (6ms) MRS detection of GABA
at 3 T in the occipital cortices of six human subjects, with an av-
erage Cramer–Rao lower bound (CRLB) uncertainty of 8%. This
suggests that reliable GABA detection is feasible at clinical ﬁeld
strengths, without the need for spectral editing. Following this
promising initial study, further investigation is required to con-
ﬁrm the initial results and to validate the use of short-TE MRS
for the detection of GABA at 3 T.
Therefore, the purpose of this study was to assess the accuracy
and reproducibility of GABA detection using the short-TE
approach under normal experimental conditions, and to investi-
gate how a change in the experimental conditions, such as
linewidth (LW) and signal-to-noise ratio (SNR), inﬂuence the ac-
curacy and reproducibility of this technique. These investigations
were performed using a methodology similar to that described
by Hancu (22,23), namely a 3-T, short-TE spectrum was simulated
by combining metabolite basis spectra in approximate physio-
logical concentrations followed by the addition of noise. The
simulated spectrum was then analysed using LCModel, and the
resulting metabolite concentration estimates were compared
with the known concentrations in the simulated input spectrum.
The above procedure was repeated many times to enable the es-
timation of the overall accuracy and reproducibility of the GABA
measurements. In addition to the simulated GABA measure-
ments described above, two in vivo experiments were performed
to further evaluate the reproducibility of short-TE MRS detection
of GABA. First, in vivo GABA measurements were performed
using both spectral editing and short-TE MRS in the occipital
cortex of 14 healthy volunteers, and the GABA concentration
estimates from short-TE MRS were compared with the gold
standard edited GABA measurement. Finally, within-session
reproducibility was assessed in the same 14 subjects using four
consecutive short-TE GABA measurements in the occipital
cortex.
METHODS
Simulated spectra
A complete set of metabolite basis spectra consisting of 22 indi-
vidual metabolites (Table 1) was simulated using an in-house
MATLAB-based implementation (MathWorks, Natick, MA, USA)
of the density matrix formalism (12). All metabolite chemical
shifts and coupling constants were taken from Govindaraju
et al. (24), with the exception of GABA, which was deﬁned using
the modiﬁed spin system parameters provided by Kaiser et al.
(25). Metabolites were simulated under the inﬂuence of an ideal
spin-echo sequence to approximate the short-TE spin-echo full-
intensity acquired localised (SPECIAL) technique (21) (2048
points; spectral width, 2000Hz; TE = 8.5ms) with a ﬁeld strength
of 3 T. Lipid and MM signals were simulated using the same
Gaussian basis functions that are simulated by default within
the LCModel software (Table 2). A residual water basis spectrum,
modelled as a two-proton singlet at 4.7 ppm, was also simulated.
All basis spectra were line broadened according to the desired
LW of the ﬁnal spectrum, and an additional line-broadening
factor was applied to lipid and MM basis spectra, as speciﬁed in
Table 2 and in the LCModel user manual. Following line broaden-
ing, a simulated spectrum was generated by combining all basis
spectra in approximate in vivo concentrations. The average metab-
olite input concentrations were estimated from the literature (24)
and are speciﬁed in Table 1, whereas the average lipid and MM in-
put concentration values (speciﬁed in Table 2) were estimated
from 12 LCModel outputs of previously obtained in vivo datasets
Table 1. List of simulated metabolites and average
concentrations
Metabolite Average concentration (mM)
Alanine 0.5
Ascorbate 0.8
Aspartate 1.5
Creatine 5.25
Phosphocreatine 4.75
g-Aminobutyric acid 1.2
Glutamine 3.2
Glutamate 9.5
Glutathione 1.5
Myo-inositol 6
Lactate 0.4
N-Acetylaspartate 12
Scyllo-inositol 0.45
Taurine 1.5
Glucose 1.0
N-Acetylaspartylglutamate 1.5
Phosphoethanolamine 1.3
Glycerophosphocholine 1.0
Phosphocholine 0.6
Glycine 0.7
Serine 0.4
b-Hydroxybutyrate 0.1
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acquired in the occipital cortex of normal subjects using the rele-
vant pulse sequence and timing parameters. As with the metabo-
lites, the concentrations of each of the six MMs and lipid signals
were allowed to vary independently of each other. Normally dis-
tributed random noise was then added to the simulated spectrum
to achieve the desired SNR, which was deﬁned as the maximum
metabolite peak height divided by the standard deviation of the
added noise. For a given SNR and LW, the above procedure was
repeated 500 times with different noise seeds. In each of the
500 repetitions, to account for normal subject-to-subject varia-
tion, the input concentration of each basis spectrum was
allowed to vary randomly with a standard deviation of 15% of
its mean value. The only exception to this was the residual water
signal, which was assigned an average value of 0mM and a stan-
dard deviation of 20mM.
Up to this point in the simulation process, 500 simulated
spectra will have been generated in which the experimental con-
ditions (LW and SNR) are identical, and the relative metabolite
concentrations will vary as they might in a normal human popu-
lation. Then, the same procedure was repeated for different sets
of experimental conditions. In total, every combination of 11 dif-
ferent LW values (ranging from 2 to 12Hz in integer steps) and
18 different SNR values (ranging from 50 to 900, in steps of 50)
was tested, for a total of 198 experimental conditions and
99 000 simulated spectra. Each spectrum was then processed
twice in LCModel; once without a baseline ﬁtting component
(achieved by setting ‘NOBASE= T’) and once using the default
LCModel baseline setting, in which LCModel attempts to ﬁnd
the smoothest possible baseline that is still consistent with the
data. For analysis of the simulated data in this study, the
baseline-free analysis is the more appropriate option, as all of
the peaks in the simulated spectra (with the exception of the tail
of the residual water peak) should be accounted for by the basis
set. However, a second analysis was performed using the default
baseline setting to examine the effect of an incorrect baseline
model on the accuracy and reproducibility of GABA concentra-
tion estimates. Both LCModel analyses were performed using
the same basis set as was employed to generate the simulated
datasets and the LCModel estimates of the metabolite concen-
trations, and CRLB uncertainties were recorded for each analysis.
Critically, the metabolite input concentrations are precisely
known for each simulated spectrum; therefore, it is possible to
assess the accuracy and reproducibility of the metabolite con-
centration estimates obtained from LCModel.
Assessment of measurement bias and reproducibility
For each set of experimental conditions, the measurement bias
and reproducibility were assessed. Measurement bias was
assessed by calculating the mean estimation error (%EE), which
was deﬁned as the average percentage difference between the
estimated and actual GABA concentration values:
%EE ¼ 1N
XN
i
Cestimatedi  Cactuali
Cactuali
 100 ¼ 1
N
XN
i
Ei
Cactuali
 100 [1]
where Cestimated is the concentration estimate from LCModel,
Cactual is the known input concentration, updated to correctly
account for subject-to-subject variation in the data, E is the
difference between the estimated and actual metabolite concen-
trations and N is the total number of simulated spectra per ex-
perimental condition (500). Reproducibility was assessed by
calculating the reproducibility error (%ER). This was performed
by ﬁrst plotting the measured GABA concentrations versus the
actual GABA input concentrations and performing a linear
least-squares ﬁt to the data. %ER was then given by the standard
deviation of the values of the ﬁtted residuals, divided by the av-
erage of the estimated concentration values:
%ER ¼
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[2]
where Cﬁt is the concentration calculated from the linear data ﬁt
described above and ei are the ﬁtted residuals. By this deﬁnition,
%ER is expressed as a percentage and provides an approximate
measure of the coefﬁcient of variation. It should be noted that,
because the reproducibility error %ER is expressed relative to
the average measured value Cestimated, its value is dependent
on the measurement bias. Therefore, it is informative to deﬁne
a second measure of the reproducibility error (%ER2), which is in-
dependent of measurement bias. This is achieved by, instead, ex-
pressing the reproducibility error relative to the average actual
concentration value Cactual. Although this is no longer a true
measurement of the coefﬁcient of variation, it provides a means
of assessing the reproducibility independently of any potential
measurement bias.
Table 2. Details of simulated lipid (Lip) and macromolecule (MM) basis spectra
Lipid/macromolecule Frequency (ppm) Line-broadening factor (Hz) Amplitude (# protons) Concentration (mM)
MM09 0.91 21.0 3 9.0
Lip20 2.04 24.6 1.33 1.0
2.25 18.5 0.67
1.95 24.6 0.87
MM20 2.08 22.2 1.33 16.0
2.25 24.6 0.33
1.95 18.5 0.33
3.00 24.6 0.40
MM12 1.21 24.6 2.0 3.75
MM14 1.43 24.6 2.0 8.0
MM17 1.67 21.0 2.0 4.0
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In vivo experiments
All volunteers (n= 14; age, 23.3 5.4 years; eight women, six
men) provided informed, written consent and were scanned on
a 3-T Siemens TIM Trio scanner (Erlangen, Germany) with a body
coil transmitter and a 32-channel receive head array. Both short-
TE and edited GABA spectra were acquired in the same scan ses-
sion from the same localised region measuring 2.5 2.5 2.5
cm3 in the occipital cortex. Shimming was performed using
the vendor-provided automated shim tool. Short-TE MR spectra
were acquired using the SPECIAL sequence (4096 points; spectral
width, 4000Hz; TR/TE = 3000/8.5ms; 192 averages) and edited
GABA spectra were acquired using the MEGA-SPECIAL sequence
(2048 points; spectral width, 2400Hz; TR/TE = 3000/68ms; 192
averages). The MEGA-SPECIAL sequence was implemented with
20-ms editing pulses and an MM-unsuppressed editing
scheme (12). To limit the amount of frequency drift in any single
scan, the MEGA-SPECIAL acquisition was broken into three
blocks of 64 averages, and a system frequency adjustment was
performed prior to the start of each acquisition block. For
both short-TE and edited acquisitions, outer volume suppres-
sion was applied prior to each scan to saturate spins on all
six sides of the region of interest, and VAPOR (variable power
radiofrequency pulses with optimised relaxation delays) water
suppression was used (19). Finally, eight averages of water-
unsuppressed data were also acquired with the same outer
volume suppression scheme as above.
Post-processing and analysis
The same post-processing chain was applied to both the edited
and short-TE datasets. First, 32-channel data were recombined in
a weighted fashion, with coil weights and phases determined
using the magnitude and phase, respectively, of the ﬁrst time
domain point of the water-unsuppressed data. Following coil re-
combination, the subspectra resulting from SPECIAL pre-
inversion on/off scans were subtracted from each other,
resulting in properly localised scans. Following subtraction of
the subspectra, a strict procedure to remove motion-corrupted
scans was employed. To identify motion-corrupted scans, a met-
ric was developed to measure the ‘unlikeness’ of each scan to
the average of all scans. Speciﬁcally, an ‘unlikeness metric’ was
calculated for each individual scan by subtracting the scan from
the average of all scans (to obtain a difference spectrum) and
then taking the root-mean-square of all of the spectral points
in the difference spectrum. Scans whose ‘unlikeness metrics’ fell
more than 2.6 standard deviations above the average were
deemed to have been corrupted by motion, and were removed.
The 2.6 standard deviation threshold was determined from expe-
rience to be fairly successful at removing outlier scans without
removing uncorrupted averages. Following the removal of
motion-corrupted scans, but prior to signal averaging, a fre-
quency and phase drift correction was performed. This was
achieved by least-squares ﬁtting of each scan to the ﬁrst scan
in the series, using frequency and phase as adjustment parame-
ters. To reduce computational load, this procedure was
performed in the time domain, using only the ﬁrst 40ms of data.
For the MEGA-SPECIAL edited data, both the removal of motion-
corrupted scans and the frequency and phase alignment were
performed separately for edit-on and edit-off spectra, with the
constraint that the number of edit-on and edit-off scans removed
must be equal. Following frequency and phase alignment of the
scans, signal averaging was performed, resulting in a fully
processed short-TE spectrum, and fully processed edit-on and
edit-off MEGA-SPECIAL data. The edit-on and edit-off scans in
the MEGA-SPECIAL data were then manually frequency and
phase aligned to minimise the residual choline difference sig-
nal, and the edit-on and edit-off scans were then subtracted,
resulting in three fully processed difference-edited spectra
(one for each of the three acquisition blocks). Finally, the three
fully processed MEGA-SPECIAL data blocks were combined
using the same automated time domain frequency and phase
alignment algorithm as used for drift correction, resulting in a
single fully processed difference edited spectrum.
All experimentally acquired short-TE SPECIAL MRS data
were analysed in LCModel using the default baseline setting
and the same basis set as used for the analysis of the simu-
lated data as described above. Edited MEGA-SPECIAL MRS
data were analysed by peak ﬁtting using jMRUI software
(26), according to the method described previously (12). Me-
tabolite concentration estimates were corrected for T2 relaxa-
tion during TE by assuming T2 values of 88 and 116ms for
GABA and creatine, respectively.
Within-session reproducibility was assessed by splitting the
previously acquired short-TE SPECIAL data into four equal and
consecutive blocks, each containing 48 averages. Each of these
four blocks was then pre-processed identically, as described
above, with the sole restriction that the same number of aver-
ages was discarded from each of the four blocks for removal of
motion corruption. Each of the four processed datasets was then
analysed using LCModel employing the default baseline setting,
and the GABA concentration estimates were recorded. The coef-
ﬁcient of variation of the GABA estimates across the four scan
blocks was then calculated for each subject.
For the measurement of SNR in experimental data, the ‘signal’
was deﬁned as the maximum intensity of the real part of the me-
tabolite signal between 0.2 and 4.2 ppm, which always
corresponded with the N-acetylaspartate (NAA) peak. The ‘noise’
was calculated by performing a second-order polynomial de-
trend of each of the spectral regions between [–2.5, –1.5], [–1.5,
–0.5], [10, 11] and [11, 12] ppm, and then taking the average of
the standard deviations of the real parts of the signals in these
regions.
RESULTS
The contour plots in Figure 1 illustrate the measurement bias and
reproducibility errors of GABA estimates as a function of LW
and SNR for the simulated data when the baseline component
is omitted from LCModel ﬁtting. The measurement bias (%EE),
reproducibility error (%ER), average CRLB and absolute reproduc-
ibility error (%ER2) are shown in Figures 1a–d, respectively.
Figure 2 illustrates the same parameters as in Figure 1 when
using the default baseline setting in LCModel instead of the
baseline-free option. The measurement bias (%EE), reproducibility
error (%ER), average CRLB and absolute reproducibility error (%ER2)
are shown in Figures 2a–d, respectively.
Figure 3a shows a representative in vivo spectrum acquired
using the short-TE SPECIAL sequence, together with an
anatomical image showing the location of the volume of
interest in the occipital cortex. Across the 14 subjects
scanned, the average LW was 5.5 0.8 Hz and the average
SNR was 665 93. The average CRLB for GABA, as measured
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using LCModel, was 11.7 2.8%. Figure 3b shows an example
of an edited spectrum acquired using the MEGA-SPECIAL se-
quence in the same subject and voxel.
In Figure 4, the GABA concentrations measured with short-TE
SPECIAL MRS are plotted against the edited GABA measure-
ments made using MEGA-SPECIAL. A signiﬁcant positive linear
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Figure 1. Contour plots showing mean estimation error (%EE) (a), reproducibility error (%ER) (b), average Cramer–Rao lower bound (CRLB) (c) and
absolute reproducibility error (%ER2) (d) of g-aminobutyric acid (GABA) for simulated data as a function of linewidth (LW) and signal-to-noise ratio
(SNR). LCModel analysis was performed with no baseline component by setting ‘NOBASE= T’.
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relationship between the two measures was observed (R= 0.58,
p< 0.05).
Figure 5a shows one of 500 simulated spectra generated with
similar experimental conditions to the in vivo data in Figure 4
(LW= 6Hz; SNR = 650). Figure 5b shows the estimated GABA
concentrations from each of the 500 spectra (measured using
the default baseline setting in LCModel) plotted versus the actual
GABA concentrations. Under these experimental conditions,
GABA concentrations are systematically underestimated, and a
strong positive correlation is observed between the estimated
and actual GABA concentrations (R= 0.84). For these simulated
data, the calculated values of %EE, %ER, average CRLB and %ER2
were –33.7%, 8.9%, 10.3% and 5.9%, respectively, when using
the default baseline setting of LCModel.
Across the 56 shortened acquisitions generated for the
investigation of within-session reproducibility, the average LW
was 5.5 0.8 Hz and the average SNR was approximately half
of the average SNR values for the full acquisitions (340 53).
The average CRLB for GABA, as measured using LCModel, was
12.6 2.0%. For simulated data under similar experimental
conditions (LW= 6; SNR= 350), the calculated values of %EE, %
ER, average CRLB and %ER2 were –21.8%, 9.0%, 12.2% and
7.0%, respectively, when using the default baseline setting of
LCModel.
Within-session reproducibility is illustrated in Figure 6 using a
box plot, with each box representing four separate GABAmeasure-
ments from a single subject. The average coefﬁcient of variation
across all 14 subjects was 8.7 4.9%. Also plotted in Figure 6 are
the GABA concentration estimates obtained from the full, 192
average, short-TE spectra (black dots). On average, GABA
estimates obtained using the full spectra are 14% lower than those
obtained using the partial spectra. This is consistent with the con-
tour plot of %EE in Figure 2a, which predicts increasing negative
bias in GABA concentration estimates with increasing SNR.
Figure 7 shows two examples of instances in which the %ER
and CRLB estimates are not indicative of the true reproducibility.
In the ﬁrst example, we consider the data simulated with the
broadest LW (LW=12Hz) and the lowest SNR (SNR= 50) when
analysed using the default baseline setting in LCModel. An
example of one of these 500 simulated spectra is shown in
Figure 7a. Under these experimental conditions, both %ER and
the average CRLB are below 20% (15.9% and 19.0%, respectively;
Fig. 2), indicating relatively reproducible GABA measurements.
However, as shown in Figure 7c, there appears to be a poor corre-
lation between the estimated versus actual GABA concentrations
at this LW and SNR (dots, R = 0.30). Therefore, in this case, the
%ER and CRLB metrics seem to overestimate the reproducibility
of the GABA measurements. In the second example, we consider
the data simulated with LW=9Hz and SNR=500, again when
analysed using the default baseline setting in LCModel. An
example of one of these 500 simulated spectra is shown in
Figure 7b. Under these experimental conditions, both %ER and
the average CRLB are above 20% (23.5% and 25.4%, respectively;
Fig. 2), indicating unreliable GABA measurements. However,
as shown in Figure 7c, there is a good correlation between
the estimated and actual GABA concentrations at this LW and
SNR (squares, R = 0.72). Therefore, in this case, the %ER and
CRLB metrics tend to underestimate the reproducibility of the
GABA measurements.
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Figure 3. Representative short-TE spin-echo full-intensity acquired
localised (SPECIAL) [(a), TR/TE= 3000/8.5 ms, 192 averages] and edited
Mescher–Garwood (MEGA)-SPECIAL [(b), TR/TE= 3000/68 ms, 192 aver-
ages] MRS data from a 2.5 2.5 2.5-cm3 volume of interest in the
occipital cortex. Both datasets demonstrate very good spectral quality
and small residual signals, indicating a good ﬁt.
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Figure 4. Comparison of g-aminobutyric acid/creatine (GABA/Cr) concen-
tration estimates obtained using both short-TE spin-echo full-intensity
acquired localised (SPECIAL) (y axis) and edited Mescher–Garwood
(MEGA)-SPECIAL (x axis). A signiﬁcant positive relationship is observed
(R = 0.58, p< 0.05), suggesting that short-TE SPECIAL measurements
correlate well with gold-standard edited measurements of GABA.
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DISCUSSION
LCModel baseline
As discussed in the Methods section, the most appropriate
choice of LCModel baseline for the analysis of the simulated data
in this study is the option in which the baseline component is
omitted from the ﬁt. The contour plots shown in Figure 1 demon-
strate that, when the appropriate baseline setting is used,
LCModel is able to estimate the GABA concentration with fairly
good reproducibility. As the experimental conditions improve
(as SNR increases and LW decreases), both the mean estimation
error (%EE, Fig. 1a) and the reproducibility errors (%ER, Fig. 1b;
%ER2, Fig. 1d) decrease, as expected. The default baseline option
in LCModel, however, includes a substantial baseline component
in the ﬁt, and is an inappropriate choice for analysis of the simu-
lated spectra in this study, as all of the peaks in the simulated
spectra (with the exception of the tail of the residual water peak)
should be accounted for by the basis set. Therefore, the contour
plots in Figure 2 illustrate the ability of LCModel to reproducibly
estimate GABA concentrations, even when an incorrect baseline
model is used. The most striking side effect of using an incorrect
baseline model is that the mean estimation error no longer de-
creases as SNR increases (Fig. 2a). Instead, as SNR increases
above 200, LCModel begins to underestimate the GABA concen-
trations, suggesting that, as SNR increases, more and more of the
GABA signal may be incorrectly attributed to the baseline. In
addition, the known MM resonances were modelled individu-
ally and no constraints were placed on their relative intensities,
which may also have contributed to bias in the ﬁt. Measuring
the MM baseline explicitly, or constraining the relative intensi-
ties of the various baseline components in the model, may help
to reduce measurement bias in the ﬁt, and will be the subject of
future work. Although the use of an incorrect baseline model
appears to have a detrimental effect on the GABA measurement
bias, the reproducibility error is not affected as severely. Indeed,
provided that SNR is greater than or equal to 150, and LW is less
than or equal to 9 Hz (criteria that can be satisﬁed by many ex-
perimental MRS data), the GABA reproducibility error (%ER2) re-
mains below 20%, which suggests very good reproducibility
despite the use of an incorrect baseline model. To summarise
this ﬁnding with regard to the LCModel baseline, if the baseline
model is not an accurate representation of the actual spectral
baseline, LCModel GABA estimates may contain systematic bias,
but, provided that the data satisfy basic quality criteria (LW ≤
9Hz; SNR ≥ 150), simulations indicate that LCModel can provide
reproducible estimates of GABA concentration.
Misleading %ER and CRLB estimates
One unexpected ﬁnding of this study is that the %ER and CRLB
estimates are not always indicative of the true reproducibility
of the measurement, as shown in Figure 7. To explain these mis-
leading reproducibility error and CRLB estimates, we need to
consider that both of these metrics estimate the uncertainty of
the measurement relative to the value of the measurement itself.
In the case of Figure 7a (LW=12Hz; SNR=50), the GABA concen-
trations are greatly overestimated, as can be seen from both the
scatter plot in Figure 7c, where the estimated GABA concentrations
are much greater than the actual concentrations, and the con-
tour plot of %EE in Figure 2a (%EE =+76%). As a result, themeasure-
ment uncertainties appear as a small percentage of the average
estimated value, resulting in small reproducibility error and
CRLB estimates. Conversely, in the case of Figure 7b (LW= 9Hz;
SNR=500), the GABA concentrations are greatly underestimated
(%EE = –58.4%), resulting in inﬂated reproducibility error and
CRLB estimates. Therefore, both CRLB and %ER estimates are
inﬂuenced by measurement bias, with positive measurement
biases tending to result in an underestimation of the CRLB and
%ER values, and negative measurement biases tending to result
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Figure 5. (a) Example simulated data with linewidth (LW) and signal-to-noise ratio (SNR) corresponding to typical experimental conditions observed
with the full spin-echo full-intensity acquired localised (SPECIAL) acquisition in the occipital cortex (LW=6 Hz; SNR= 650). (b) Scatter plot showing the
estimated versus actual g-aminobutyric acid (GABA) concentration for all 500 simulated spectra with these experimental conditions.
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Figure 6. Box plot diagram illustrating within-session reproducibility for
all 14 subjects scanned. Box plot data were generated by breaking the
short-TE spin-echo full-intensity acquired localised (SPECIAL) acquisition
into four separate and consecutive blocks, and analysing each separately.
Also shown are the g-aminobutyric acid (GABA) estimates from the full
SPECIAL acquisition (dots). Cr, creatine.
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in an overestimation of the CRLB and %ER values. For this reason,
we have introduced the absolute measure of reproducibility
error (%ER2), which is independent of measurement bias. This
metric tends to more accurately reﬂect the reproducibility error
in cases in which there is a large measurement bias. For example,
in the case of Figure 7a, %ER2 is 27.4% and, in the case of Figure 7b,
%ER2 is 9.9%. The misleading nature of CRLB estimates suggests
that the use of CRLB values as acceptance criteria for MRS
metabolite measurements (i.e. CRLB< 20%) may not be valid in
all situations.
GABA reproducibility under realistic
experimental conditions
The results shown in Figure 5 demonstrate that, under the exper-
imental conditions corresponding to those observed in the
in vivo experiments performed here (LW=6Hz; SNR= 650), simu-
lations predict that, although the GABA concentration will be
systematically underestimated by approximately 34%, the repro-
ducibility of the measurements (%ER = 8.9%, %ER2 = 5.9%) is com-
parable with previously published reproducibility values for
edited measurements of GABA at the same ﬁeld strength
(14,15). This high reproducibility is indicated by the strong posi-
tive correlation between estimated GABA concentrations and
actual concentrations shown in Figure 5b (R= 0.84). Providing
further evidence of the reproducibility of short-TE GABA measure-
ments under these experimental conditions is the observation
of a signiﬁcant positive correlation (R = 0.58, p< 0.05) between
short-TE GABA measurements and gold-standard edited GABA
measurements in the same voxel (Fig. 4).
Under the experimental conditions corresponding to the
shortened 2.4-min acquisitions performed here (LW=6Hz; SNR=
350), simulations predict that GABA concentrations will be sys-
tematically underestimated by 21.8%, and that the reproducibil-
ity of the measurements (%ER = 9.0%, %ER2 = 7.0%) is only
marginally worse than when using the full 9.6-min acquisition.
Furthermore, from the in vivo study of within-session reproduc-
ibility, the average coefﬁcient of variation of short-TE GABA mea-
surements was calculated to be 8.7 4.9%, which agrees well
with simulation, and compares favourably with previously pub-
lished reproducibility values for edited measurements of GABA
at the same ﬁeld strength (14,15).
The in vivo experiments performed here consisted of a short-
TE SPECIAL acquisition with a duration of 9.6min in a voxel
measuring 15.625 cm3. This is fairly representative of a typical
short-TE MRS experiment at 3 T, with the exception of the voxel
size, which is approximately double the conventional size of
8 cm3 (21). This larger voxel size was chosen to enable matching
of the voxel sizes between the short-TE MRS acquisition and the
edited experiment, as edited MRS experiments are typically ac-
quired with larger voxels (22.5 cm3 or greater) (8,12,14) because
of the relatively low sensitivity of the technique.
It should be noted that the SNR observed when using the
shortened 2.4-min acquisition combined with a relatively large
(15.625-cm3) voxel would be almost identical to the SNR that
would be achievable using the more conventional ~10-min
acquisition combined with a small (8-cm3) voxel. Therefore, one
could expect similar reproducibility of GABA estimates under
these circumstances. According to the results of both the simula-
tions and the experiments performed here, improvement of the
SNR when using the default baseline setting in LCModel tends to
result in larger (more negative) measurement bias, with only
marginal improvements in reproducibility.
It is recognised that the occipital cortex is one of the more
favourable areas of the brain for single-voxel MRS in terms of
the LW and SNR that can be typically achieved. Indeed, the
SNR achieved in the occipital cortex in this study is higher than
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Figure 7. Illustration of misleading Cramer–Rao lower bounds (CRLBs). (a)
Example simulated data with linewidth (LW) and signal-to-noise ratio (SNR)
corresponding to the worst simulated conditions (LW=12 Hz; SNR=50).
The average CRLB for simulated data with these experimental conditions
was less than 20%, indicating good reproducibility. (b) Example simulated
data with LW=9 Hz and SNR=500. The average CRLB for simulated data
with these experimental conditions was greater than 20%, indicating poor
reproducibility. (c) Scatter plot showing estimated versus actual g-
aminobutyric acid (GABA) concentration for all 500 simulated spectra with
experimental conditions of (a) (dots) and (b) (squares). Note that, despite
the higher CRLB, case (b) appears to show better data reproducibility.
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typical acquisitions in many other brain regions, and it should
be emphasised that GABA detection using short-TE MRS may
not be reliable in areas of the brain associated with poor shim-
ming and low SNR. Future experimental studies are required to
assess the performance of this technique in different regions of
the brain.
Because large measurement biases are observed under
certain experimental conditions, short-TE MRS at 3 T, combined
with LCModel analysis, is currently not likely to be a reliable
method of obtaining absolute GABA concentration measure-
ments. However, in the vast majority of clinical MRS studies,
absolute metabolite concentration measurements are not
required. Rather, the main requirement for most studies is
the ability to detect changes in metabolite concentrations, or
differences between groups. Therefore, measures of reproduc-
ibility (%ER, %ER2) are usually the most important quantity for
determining the measurement efﬁcacy, and, under the experi-
mental conditions investigated in this study, the values of both
%ER and %ER2 are acceptably small (<20%), indicating repro-
ducible GABA measurements.
It should also be noted that, because the measurement bias
varies as a function of both LW and SNR, differences in LW and
SNR between individual datasets should be viewed as a possible
source of error within a study. Therefore, it is very important to
ensure similar spectral quality across datasets in a study. This
can be achieved by enforcing strict requirements on both the
LW and SNR of each dataset, and by rejecting datasets that do
not meet these requirements. Furthermore, in studies designed
to evaluate correlations between GABA concentrations and
other clinical variables, it should be determined whether individ-
ual differences in LW and SNR are correlated with the clinical var-
iables. If LW and SNR are correlated with the clinical variables of
interest, these parameters should be included as covariates in
the statistical analyses.
The simulated spectra in this study were designed to approx-
imate the normal range of metabolite concentrations in a group
of healthy humans. In the case of pathology, when one or more
metabolites may be outside of the normal range, the results of
this study may not be applicable.
The simulated data in this study have been generated using a
number of simplifying assumptions. First, as the basis spectra
used to ﬁt the simulated data in LCModel were identical to the
basis spectra used to generate the simulated data itself, the esti-
mates of measurement bias and reproducibility represent a
‘best-case scenario’. In in vivo data, some differences may exist
between the actual metabolite signals and the simulated basis
spectra used to analyse the data, resulting in some additional
quantiﬁcation errors. However, these differences are assumed
to be very small, and this assumption is supported by the excel-
lent correspondence observed between simulated and acquired
metabolite signals (12,25). Second, simulated spectra do not take
into account certain experimental factors, such as subject mo-
tion (and other ghost signals), frequency drift and phase drift.
It is assumed that the effect of neglecting these factors is small,
and this assumption is supported by the fact that all in vivo
acquisitions employed strict pre-processing routines, such as the
rejection of motion-corrupted scans and frequency and phase
drift corrections to minimise the effects of these factors. Finally,
possible differences in T2 relaxation rates between individual
metabolites were not taken into account in either the generation
of the simulated MR spectra or the analysis of simulated and
experimental data.
CONCLUSIONS
Both simulations and in vivo experiments indicate that short-TE
SPECIAL MRS is capable of providing reproducible GABA mea-
surements in the occipital lobe at 3 T, even when an incorrect
baseline model is used in the analysis of the data. However,
the results of the simulations also suggest that the accuracy of
GABA concentration estimates obtained with short-TE MRS is
dependent on the experimental conditions, and should there-
fore be used with caution. Future studies are required to deter-
mine the efﬁcacy of short-TE MRS for the detection of GABA in
other brain regions, especially those associated with poor shim
and lower SNR.
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